Methicillin-resistant
Staphylococcus aureus (MRSA) was identified for the first time in the 1960s, showing the response of
S. aureus to extensive exposure to penicillins. Increase in MRSA infections seemingly reflects the growing impact of medical interventions, use of various devices, aging (
1, 2) and partially is an outcome of advances in patient care and pathogens ability to survive in changing environments (
1). The use and probably overuse of antibiotics contribute to the emergence of resistance. Morbidity and mortality rates of MRSA infections in community settings are considerable, just as nosocomial MRSA infections. MRSA now accounts for 160% of
S. aureus isolates in intensive care units (ICUs) of the United States hospitals (
3) and kills about 19000 hospitalized American patients annually; this is close to the number of deaths because of acquired immune deficiency syndrome (AIDS), viral hepatitis and tuberculosis combined (
4,
5). Community-associated MRSA infections were at first identified in children with bloodstream infections who had no prior health-care exposure (
6) and growingly reported as a major cause for skin infections and abscesses among healthy adults (
7). The incidence of MRSA varies geographically; for example in Europe, a considerable variation exists, with only 0.5% in Iceland but 44% in Greece from 1999 to 2002 (
8). There is a constant need for novel antimicrobial substances due to rapid appearance of multiple drug-resistance bacteria (
9). Herbal medicines are recognized as a protection system against pathogenic bacteria (
10). The genus
Juglans (family Juglandaceae) is comprised of several species and is distributed all around the world. Several parts of green walnuts such as its shell, kernel and seed, bark and leaves are used in the pharmaceutical and beauty industries (
11, 12). Walnut (
Juglans regia Li.) bark is used as a toothbrush and as a dye for coloring the lips in some countries (
13). It has been claimed that it owns anti-inflammatory and anticancer properties, helps purifying the blood; it is diuretic and has laxative activities. It contains several therapeutically active constituents, particularly polyphenols (
14).
Juglans regia stem bark contains chemical constituents, namely β-sitosterol, ascorbic acid5, juglone, folic acid, gallic acid, regiolone and quercetin-3-α-L-arabinoside (
9). Antifungal, antibacterial and antioxidant activities of this plant have been studied by several researchers (
15, 16).
The extract of
Juglans regia bark has shown a wide spectrum of antimicrobial activity in a dose-dependent manner. The acetone extract is the most effective preparation when used as an antimicrobial agent against oral micro-flora (
9). This extract has either synergistic or additive effect when tested with a broad spectrum of antibacterial drugs (
13). The increasing emphasis on plant studies in the field of medicine is because of antibiotic-resistant bacteria, side effects of chemical antibiotics and their high cost for developing countries. The barks of different species of
Juglans regia have been chemically analyzed in numerous studies. Major components in obtained essential oils of
Juglans regia include phenolic compounds, terpenoids, alkaloids, flavonoids and steroids (
17). It is reported that the bark of
Juglans regia Li. contains ketones like juglone, regiolone, sterol and flavonoid (
18).
Juglans regia bark is a medicinal material used in Iranian folk medicine as an antimicrobial medicine (
9).